What to Look for in Delta Earnings
Delta Air Lines is scheduled to release its third-quarter financial results on Thursday before the markets open.
All Work
Chris Lange
JetBlue Posts September Traffic Numbers
JetBlue's traffic in September increased almost 11% from September 2015, on a capacity increase of nearly 8%.
IntelliPharmaCeutics Inks New Licensing Deal With Mallinckrodt
Shares of IntelliPharmaCeutics soared after the company reported a new licensing deal with Mallinckrodt.
Social Media Short Interest Remains Mixed
Short interest in these selected social media stocks was mixed for the most recent settlement date.
Short Sellers Back Off Certain Cybersecurity Stocks
The September 30 short interest data have been compared with the previous figures, and short interest for the selected cybersecurity stocks was mixed.
Accelerated Pharma Announces Expected Price Range for IPO
Accelerated Pharma intends to price less than 2 million shares in the range of $8 to $10 for an initial public offering valued up to more than $21 million.
Major Pharma Short Sellers Grow More Selective
The September 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest was mixed.
Is Major Semiconductor Short Interest Suggesting an End to the Tech Rally?
The markets have been retreating, begging the question whether the recent tech rally is over. The latest short interest data might suggest that it is.
Short Sellers Can’t Make Up Their Minds on Major Oil
The September 30 short interest data have been compared with the previous figures, and short interest for the selected oil stocks was mixed.
Short Sellers Have Mixed Views on Major Biotechs
If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a stock implosion down the road.
Barracuda Networks Wins Big on the Bottom Line
Barracuda Networks Inc. (NYSE: CUDA) reported fiscal second-quarter financial results after markets closed on Tuesday. The company said that it had $0.21 in earnings per share (EPS) on $87.9 million in revenue. Thomson Reuters…
Biostar Pharma Skyrockets on New Chinese Product Launch
Biostar Pharmaceuticals Inc. (NASDAQ: BSPM) is watching its shares nearly double on Tuesday after the company announced that it is releasing a new product line to treat respiratory irritation and inflammation. Specifically, Biostar is launching…
SEC Posts Record Enforcement Numbers for Fiscal 2016
The SEC has announced that in its fiscal year 2016 the agency filed 868 enforcement actions, a new single year high for such actions.
Nymox Wins Big on Late-Stage Trial
Nymox Pharmaceutical shares jumped following the announcement of positive results from its late-stage prostate cancer trial.
September Traffic Report: Southwest Versus United
Both Southwest Airlines and United Continental reported their September traffic numbers on Tuesday morning. Overall, the numbers were not earth-shattering.
KemPharm Rises on Key FDA Approval
KemPharm shares saw a solid gain on Tuesday following a key FDA approval on it treatment for attention deficit hyperactivity disorder.
Rent-A-Center Gets Burned on Preliminary Q3 Results
Rent-A-Center saw its shares take a dive early on Tuesday after the company gave a preliminary report on selected third-quarter financial information.
Merrimack Pharma Rises on Positive Late-Stage Results
Merrimack Pharmaceuticals shares saw a handy gain early Tuesday after the company announced positive results for its late stage metastatic pancreatic cancer study.
Illumina Stumbles Over Q3 Sales Update
When Illumina issued an update on its sales for the third quarter, the numbers came in below what analysts were looking for, and as a result investors sent the stock lower.
Mazor Robotics Rises on Pre-Launch Orders
Mazor Robotics Ltd. (NASDAQ: MZOR) is watching its shares rise handily on Monday after the company announced that it has received the first pre-launch orders for its guidance platform for spine surgeries. The Mazor X…